1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Gene Therapy Market, By Vector
5.1 Introduction
5.2 Non-Viral Vectors
5.2.1 Oligonucleotides
5.2.2 Other Non-Viral Vectors
5.3 Viral Vectors
5.3.1 Retro Viral Vectors
5.3.2 Adeno-Associated Virus Vectors
5.3.3 Lentiviral Vector
5.3.4 Herpes Virus Vector
5.3.5 Other Viral Vectors
6 Global Gene Therapy Market, By Gene Type
6.1 Introduction
6.2 Antigen
6.3 Cytokine
6.4 Tumor Suppressor
6.5 Suicide
6.6 Deficiency
6.7 Growth factors
6.8 Receptors
6.9 Other Gene Types
7 Global Gene Therapy Market, By Delivery Method
7.1 Introduction
7.2 In Vivo
7.3 Ex Vivo
8 Global Gene Therapy Market, By Application
8.1 Introduction
8.2 DMD (Duchenne Muscular Dystrophy)
8.3 Neurological Diseases
8.4 Cancer
8.5 Hepatological Diseases
8.6 Rare Diseases
8.7 Oncological Disorders
8.8 Acute Lymphoblastic Leukemia (ALL)
8.9 Peripheral arterial disease
8.10 Other Applications
9 Global Gene Therapy Market, By End User
9.1 Introduction
9.2 Cancer Institutes
9.3 Hospitals
9.4 Research Institutes
9.5 Other End Users
10 Global Gene Therapy Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Amgen Inc.
12.2 Biogen Inc.
12.3 Bluebird Bio Inc.
12.4 Gilead Sciences Inc.
12.5 Novartis AG
12.6 F. Hoffmann-La Roche Ltd
12.7 UniQure NV
12.8 Abeona Therapeutics Inc.
12.9 Generation Bio
12.10 Poseida Therapeutics
12.11 Astellas Pharma
12.12 Voyager Therapeutics Inc.
12.12 Jazz Pharmaceuticals, Inc
12.14 GlaxoSmithKline plc
12.15 Spark Therapeutics Inc
12.16 Sarepta Therapeutics
12.17 Orchard Therapeutics
12.18 Shenzhen SiBiono GeneTech
12.19 Shanghai Sunway Biotech Co. Ltd.
12.20 CRISPR Therapeutics AG
List of Tables
Table 1 Global Gene Therapy Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Gene Therapy Market Outlook, By Vector (2021-2030) ($MN)
Table 3 Global Gene Therapy Market Outlook, By Non-Viral Vectors (2021-2030) ($MN)
Table 4 Global Gene Therapy Market Outlook, By Oligonucleotides (2021-2030) ($MN)
Table 5 Global Gene Therapy Market Outlook, By Other Non-Viral Vectors (2021-2030) ($MN)
Table 6 Global Gene Therapy Market Outlook, By Viral Vectors (2021-2030) ($MN)
Table 7 Global Gene Therapy Market Outlook, By Retro Viral Vectors (2021-2030) ($MN)
Table 8 Global Gene Therapy Market Outlook, By Adeno-Associated Virus Vectors (2021-2030) ($MN)
Table 9 Global Gene Therapy Market Outlook, By Lentiviral Vector (2021-2030) ($MN)
Table 10 Global Gene Therapy Market Outlook, By Herpes Virus Vector (2021-2030) ($MN)
Table 11 Global Gene Therapy Market Outlook, By Other Viral Vectors (2021-2030) ($MN)
Table 12 Global Gene Therapy Market Outlook, By Gene Type (2021-2030) ($MN)
Table 13 Global Gene Therapy Market Outlook, By Antigen (2021-2030) ($MN)
Table 14 Global Gene Therapy Market Outlook, By Cytokine (2021-2030) ($MN)
Table 15 Global Gene Therapy Market Outlook, By Tumor Suppressor (2021-2030) ($MN)
Table 16 Global Gene Therapy Market Outlook, By Suicide (2021-2030) ($MN)
Table 17 Global Gene Therapy Market Outlook, By Deficiency (2021-2030) ($MN)
Table 18 Global Gene Therapy Market Outlook, By Growth factors (2021-2030) ($MN)
Table 19 Global Gene Therapy Market Outlook, By Receptors (2021-2030) ($MN)
Table 20 Global Gene Therapy Market Outlook, By Other Gene Types (2021-2030) ($MN)
Table 21 Global Gene Therapy Market Outlook, By Delivery Method (2021-2030) ($MN)
Table 22 Global Gene Therapy Market Outlook, By In Vivo (2021-2030) ($MN)
Table 23 Global Gene Therapy Market Outlook, By Ex Vivo (2021-2030) ($MN)
Table 24 Global Gene Therapy Market Outlook, By Application (2021-2030) ($MN)
Table 25 Global Gene Therapy Market Outlook, By DMD (Duchenne Muscular Dystrophy) (2021-2030) ($MN)
Table 26 Global Gene Therapy Market Outlook, By Neurological Diseases (2021-2030) ($MN)
Table 27 Global Gene Therapy Market Outlook, By Cancer (2021-2030) ($MN)
Table 28 Global Gene Therapy Market Outlook, By Hepatological Diseases (2021-2030) ($MN)
Table 29 Global Gene Therapy Market Outlook, By Rare Diseases (2021-2030) ($MN)
Table 30 Global Gene Therapy Market Outlook, By Oncological Disorders (2021-2030) ($MN)
Table 31 Global Gene Therapy Market Outlook, By Acute Lymphoblastic Leukemia (ALL) (2021-2030) ($MN)
Table 32 Global Gene Therapy Market Outlook, By Peripheral arterial disease (2021-2030) ($MN)
Table 33 Global Gene Therapy Market Outlook, By Other Applications (2021-2030) ($MN)
Table 34 Global Gene Therapy Market Outlook, By End User (2021-2030) ($MN)
Table 35 Global Gene Therapy Market Outlook, By Cancer Institutes (2021-2030) ($MN)
Table 36 Global Gene Therapy Market Outlook, By Hospitals (2021-2030) ($MN)
Table 37 Global Gene Therapy Market Outlook, By Research Institutes (2021-2030) ($MN)
Table 38 Global Gene Therapy Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
